June 3, 2026
Created by Ryan Hale

Growth Hormone Peptides: How GH Secretagogues Work and What Research Shows

PEPTIDES · GROWTH HORMONE AXIS

GROWTH HORMONE PEPTIDES: HOW GH SECRETAGOGUES WORK AND WHAT RESEARCH SHOWS

If you have searched for peptides for muscle growth, you have met the same list everywhere: CJC-1295, ipamorelin, sermorelin, tesamorelin, GHRP-6, hexarelin, MK-677. They are all growth hormone peptides, or hgh peptides as the ads call them. None of them is growth hormone. Each one asks your pituitary gland to release more of your own. That is the whole idea, and it works, in the sense that growth hormone goes up (PMID 2108187, PMID 16352683). The question this page answers is the one the ads skip: does more growth hormone from a peptide turn into more muscle?

This page explains it the way a coach would: plain words, every number from a PubMed abstract or a regulator page. You get how the axis works, what growth hormone itself does to muscle in people who train, each peptide ranked by what human trials actually measured, the class side effects, and why the best peptides for muscle growth list looks very different once you sort by evidence instead of by forum. Each compound has its own deep page, linked as you go. Syringe arithmetic is on the peptide calculator.

R
Ryan Hale
Research Notes Editor · Updated October 2026

Growth hormone peptides in brief

Three numbers tell most of the story. What growth hormone itself does to lean mass in fit young people. What it does to strength. And how many of these peptides have a muscle result in a human trial.

+2.1 kglean mass

What growth hormone itself added in fit young adults across 27 study groups

A systematic review pooled 303 young, lean, fit people given growth hormone for about 20 days. Lean body mass rose 2.1 kg against controls. Strength and exercise capacity did not improve, and treated people had more swelling and fatigue (PMID 18347346). That is the ceiling the peptides are reaching for.

0strength gain

Strength improvement from growth hormone in healthy people who train

In 16 young men lifting for 12 weeks, growth hormone added more fat free mass. It added no more muscle size, strength or muscle protein synthesis than placebo. The extra mass was water and non muscle tissue (PMID 1550219). The review of all trials reached the same conclusion (PMID 18347346).

1 of 7has muscle data

Growth hormone peptides with a lean mass result from a randomised human trial

Of the seven names on every list, only MK-677 has a controlled trial measuring lean mass. It added 1.1 kg against a 0.5 kg loss on placebo over a year in healthy older adults, with no gain in strength (PMID 18981485). A GHRH analog added lean mass in older men only (PMID 9141536). The rest have hormone data or nothing.

Every figure on this page comes from a PubMed abstract or a regulator document listed at the end. Doses appear only where a trial states them. Nothing here is a recommendation to use peptides for muscle growth, and no compound on this page is approved for that purpose anywhere.

What this guide covers

Covered

How the growth hormone axis works and the two doors the hgh peptides use to open it. Where they sit in the wider family is on types of peptides.

What growth hormone itself does to muscle in healthy people who train, because that is the ceiling for every peptide below it.

The seven growth hormone peptides ranked by human evidence, with one section on each and a link to its full page.

Class side effects, the fat loss and women questions people ask, and how users actually run these compounds.

Not covered

A dose, cycle or stack for you. No regulator has approved any of these for muscle growth. This page gives no protocol.

Healing peptides. BPC-157 and TB-500 are not growth hormone peptides and do not build muscle. They sit on healing peptides.

Where to buy anything. This site does not sell or source peptides and does not link to sellers. The whole field sits on the peptides hub.

How growth hormone peptides work, in plain words

Your pituitary gland, a pea at the base of the brain, releases growth hormone in pulses, mostly at night. Two signals control the pulses. One is growth hormone releasing hormone, GHRH, from the hypothalamus. It tells the pituitary to make and release the hormone. The other is ghrelin, the hunger hormone from the stomach, which has its own receptor on the pituitary and boosts the release. Growth hormone then travels to the liver, which makes IGF-1, the slower signal that does much of the work in tissue.

Every growth hormone peptide copies one of those two signals. The GHRH analogs, sermorelin, tesamorelin and CJC-1295, are copies of GHRH, built to last longer than the natural version. The growth hormone releasing peptides, GHRP-6, GHRP-2, hexarelin and ipamorelin, are small lab made molecules that hit the ghrelin receptor. MK-677 is an oral drug that hits the same receptor; it is not a peptide, but it is on every list, so it is here.

Where growth hormone peptides actTwo doors into the same gland. Nothing here adds growth hormone itself; it asks your pituitary to release more.GHRH analogssermorelin, tesamorelin, CJC-1295Ghrelin receptor agonistsGHRP-6, GHRP-2, hexarelin, ipamorelinPituitary glandreleases GH in pulsesGHRH receptorghrelin receptorGrowth hormonein the blood, hoursLiver makes IGF-1the signal that lasts for daysBoth doors at once release more GH than either alone (PMID 2108187, PMID 7883854). That is the logic behind every stack.What has not been shown: that more growth hormone from these peptides turns into more muscle in a healthy adult who trains.Simplified. GHRPs also act in the hypothalamus. MK-677 is an oral drug, not a peptide, on the same receptor.

The two doors add up. In normal men, GHRP-6 on its own released about three times more growth hormone than GHRH on its own. The two together released more than the sum of both (PMID 7883854). That synergy was found in 1990 and it is the reason every stack pairs a GHRH analog with a GHRP (PMID 2108187). The combination of GHRH and GHRP-6 is so reliable that it became a diagnostic test for growth hormone deficiency (PMID 11030292).

YouWhat this means for you. These peptides reliably raise growth hormone. Nobody disputes that. The open question is the next step: whether that extra hormone becomes muscle in a healthy person who lifts. The next section answers it with growth hormone itself, which has been tested far more than any peptide.

What growth hormone itself does to muscle: the ceiling

If peptides for muscle growth work, the best they can do is give you the effect of more growth hormone. So the honest first question is what growth hormone does in people like you. Not in children with a deficiency, not in HIV patients, but in healthy adults who train.

The answer comes from a 2008 systematic review in the Annals of Internal Medicine. It found 27 study groups and 303 young, lean, fit people, average age 27. They got growth hormone at about 36 micrograms per kilogram a day for about 20 days. Lean body mass rose 2.1 kg against controls. Strength and exercise capacity did not improve. Lactate during exercise was higher. Treated people had more soft tissue swelling and fatigue (PMID 18347346).

The one study that trained people hard says the same thing. Sixteen young men lifted for 12 weeks on growth hormone or placebo. The growth hormone group gained more fat free mass and had higher whole body protein synthesis. But their quadriceps muscle protein synthesis, limb size and strength did not increase any more than placebo. The authors concluded the extra fat free mass was lean tissue other than skeletal muscle, mostly water (PMID 1550219).

2.1 kgLean mass gained on growth hormone in fit young adults, with no gain in strength and more swelling and fatigue (PMID 18347346). In the one study with hard training, muscle size and strength did not grow more than placebo (PMID 1550219). This is the ceiling every growth hormone peptide is reaching for.

A 2010 trial in 96 recreational athletes added one nuance. Eight weeks of 2 mg a day cut fat mass and raised lean mass through extra water. Sprint capacity improved by 3.9 percent, or 8.3 percent when men also took testosterone. Strength, power and endurance did not change. The sprint gain was gone six weeks after stopping (PMID 20439575).

So the ceiling is this: some water weight, a little fat loss, a small sprint effect, no strength, no measured muscle growth. The peptides work by raising your own hormone to a level below what those trials injected. Whatever they do, it sits under that ceiling.

YouWhat this means for you. When someone tells you a peptide builds muscle like growth hormone, remember that growth hormone itself did not build measurable muscle or strength in fit adults who train. The peptide cannot do better than the hormone it releases.

The best peptides for muscle growth, ranked by human evidence

Here is the list of peptides for muscle growth everyone searches for, sorted the honest way. Rank one is the compound with the most human body composition data, not the one with the most forum posts. Read the third column before anything else. It tells you whether anyone has ever measured muscle, or only hormones.

Growth hormone peptides ranked by what human trials have measured about muscle, not by forum popularity.
RankCompoundBest human evidence on body compositionHormone effect in peopleStatus
1MK-677 (ibutamoren)Lean mass +1.1 kg vs -0.5 kg on placebo over 1 year in 65 healthy older adults; strength and function unchanged; fasting glucose and cortisol up (PMID 18981485)Raised GH and IGF-1 to young adult levels (PMID 18981485)Never approved; oral; not a peptide
2Sermorelin (GHRH 1-29)Lean mass up in older men only, not women, after 16 weeks nightly in 19 people aged 55 to 71; skin thickness up in both (PMID 9141536)Overnight GH output up 70 to 107 percent, IGF-1 up 28 percent (PMID 9141536)Formerly approved, withdrawn for business reasons
3Tesamorelin (Egrifta)Deep belly fat down 15.2 percent vs up 5.0 percent on placebo in 412 HIV patients over 26 weeks; a fat result, not a muscle result (PMID 18057338)IGF-1 up 81 percent (PMID 18057338)FDA approved for HIV belly fat only
4CJC-1295 with DACNo body composition data. Two phase 1 trials in healthy adults, hormones only (PMID 16352683, PMID 17018654)GH up 2 to 10 times for 6 days, IGF-1 up 1.5 to 3 times for 9 to 11 days after one shot (PMID 16352683)Phase 1 only; FDA Category 2
5GHRP-6No body composition data. Used as a diagnostic test (PMID 11030292)About 3 times the GH of GHRH alone; raised cortisol and prolactin at the top dose (PMID 7883854, PMID 2108187)Never approved
6Hexarelin and GHRP-2No body composition data. Five days of GHRP-2 did not raise IGF-1 and the GH response faded (PMID 9820615)Hexarelin: prolactin up to 180 percent, cortisol about 40 percent in men (PMID 8954038)GHRP-2 is a diagnostic in Japan; hexarelin never approved
7IpamorelinNo body composition data in people. One failed phase 2 trial after bowel surgery (PMID 25331030)One GH pulse per dose, half-life 2 hours (PMID 10496658)Development stopped; FDA Category 2

Three things stand out. First, the only compound with a controlled lean mass result in healthy adults is MK-677, and it is not a peptide. The gain was 1.1 kg over a year in people aged 60 to 81, and strength did not change (PMID 18981485). Second, the two compounds with the best human records, tesamorelin and sermorelin, were tested for belly fat and ageing, not for muscle in lifters. Third, the three most popular gym peptides, CJC-1295, ipamorelin and GHRP-6, have no body composition data in people at all.

One more data point belongs here even though you cannot buy it. Capromorelin, an oral growth hormone secretagogue, was tested in 395 older adults for up to two years. Lean mass rose 1.4 kg against 0.3 kg on placebo at six months, and a tandem walk test improved. Side effects included fatigue, insomnia and small rises in fasting glucose and insulin resistance. The programme was stopped early (PMID 19174493). It is the best proof that the class can add lean mass in older people, and the best warning about what comes with it.

Seven small peptide vials in a row with number labels 1 to 7 on a dark laboratory bench
Seven names, one ranking. Only the first has a lean mass result in a human trial, and that gain came with no strength and a rise in blood sugar.
YouWhat this means for you. If you want the growth hormone peptide with the most human muscle data, it is MK-677, and the data say 1.1 kg of lean mass in a year, no strength, and worse blood sugar. If you want a prescription drug with a label, it is tesamorelin, for belly fat. Everything else on the list has never had its muscle effect measured in a person.

Each growth hormone peptide, in one paragraph

MK-677 (ibutamoren)

An oral pill that hits the ghrelin receptor, so it does what the injected GHRPs do without a needle. In a year long trial of 65 healthy older adults it raised growth hormone and IGF-1 to young adult levels. It added 1.1 kg of fat free mass against a loss on placebo, and did not change strength or function. Appetite rose, fasting glucose rose by about 5 mg/dL, insulin sensitivity fell, and cortisol went up (PMID 18981485). It is the only compound on this page with a muscle number from a controlled trial, and the number is small.

Sermorelin

The first 29 building blocks of natural GHRH. It clears in minutes, so it is injected nightly. In 19 people aged 55 to 71, four months of nightly shots raised overnight growth hormone output 70 to 107 percent and IGF-1 28 percent. Lean mass rose in the men but not the women, skin got thicker in both, and the men reported better wellbeing and libido (PMID 9141536). It was a prescription drug for years and was withdrawn for business reasons, not safety. Compared in detail on CJC-1295 explained.

Tesamorelin (Egrifta)

A stabilised full length GHRH and the only name here with a phase 3 trial and an FDA label. In 412 HIV patients with belly fat, 2 mg a day for 26 weeks cut deep belly fat 15.2 percent while placebo rose 5.0 percent. IGF-1 rose 81 percent. Blood sugar did not change (PMID 18057338). It is approved for that one condition. Nobody has tested it for muscle in healthy lifters. Full story on tesamorelin explained.

CJC-1295

A GHRH copy with a hook that binds albumin in the blood, so one shot works for about a week. In healthy adults, one injection raised growth hormone 2 to 10 times for six days or more. IGF-1 rose 1.5 to 3 times for 9 to 11 days (PMID 16352683). The pulses survived; the gaps between them rose 7.5 times (PMID 17018654). Two phase 1 trials, both in 2006, both hormones only, and the no DAC version in the blend vials was never in either. Full story on CJC-1295 explained.

Ipamorelin

A five building block GHRP sold as the clean one because it did not raise cortisol or prolactin in pigs (PMID 9849822). In healthy men one dose gives one growth hormone pulse that peaks at 40 minutes and fades within hours (PMID 10496658). Its only efficacy trial in people, after bowel surgery, failed (PMID 25331030). No body composition data exist. Full story on ipamorelin explained.

GHRP-6 and GHRP-2

The original GHRPs from the late 1980s. In normal men GHRP-6 released far more growth hormone than GHRH, and the two together were synergistic (PMID 2108187, PMID 7883854). That is the basis of every stack. At the top dose it also doubled prolactin and cortisol (PMID 2108187). GHRP-6 is known for strong hunger. GHRP-2 given daily for five days in healthy young men produced a fading growth hormone response and no rise in IGF-1 (PMID 9820615). Neither has body composition data.

Hexarelin

The most potent GHRP for growth hormone release, and the least selective. In a dose response study in men it raised prolactin by up to 180 percent and cortisol by about 40 percent (PMID 8954038). No body composition data. Never approved.

YouWhat this means for you. Seven compounds, one with a muscle number, two with real human programmes for other conditions, four with hormone curves only. That is the whole field. The deep pages for CJC-1295 and ipamorelin go through every trial line by line.

Side effects of peptides for muscle growth, by the evidence

The side effects of growth hormone peptides are mostly the side effects of more growth hormone. Add whatever the specific molecule brings, and whatever is in the vial. The good news is that this class has more human safety data than the healing peptides. The bad news is that the data point the same way every time: water, joints, blood sugar, cortisol.

Side effects of growth hormone peptides and the evidence behind each one.
EffectStrongest evidenceRead it as
Water retention, swelling, joint and muscle painMore soft tissue swelling and fatigue on growth hormone itself in fit adults (PMID 18347346); mild leg swelling and muscle pain on MK-677 (PMID 18981485); fluid retention and joint pain listed as class effects in self use (PMID 42395176)Expected from more growth hormone
Blood sugar and insulin resistanceFasting glucose up and insulin sensitivity down on MK-677 over a year (PMID 18981485); glucose and insulin resistance up on capromorelin (PMID 19174493); dysglycaemia a listed class effect (PMID 42395176)The most consistent metabolic signal
Cortisol and prolactinDoubled at the top GHRP-6 dose (PMID 2108187); prolactin up to 180 percent and cortisol about 40 percent on hexarelin (PMID 8954038); cortisol up on MK-677 (PMID 18981485). Ipamorelin spared both in pigs, untested in people (PMID 9849822)Real for most GHRPs
HungerAppetite rose on MK-677 for a few months (PMID 18981485); appetite change is a class effect (PMID 42395176); GHRPs act on the hunger hormone receptorExpected from the mechanism
Fatigue, insomnia, tinglingFatigue and insomnia on capromorelin (PMID 19174493); fatigue on growth hormone (PMID 18347346)Trial data
Response fadesFive days of daily GHRP-2: growth hormone response fell by about a third and IGF-1 did not rise (PMID 9820615)Tolerance in one short study
Cell growth concernRaised IGF-1 for months is the intended effect; a 2026 review calls the cancer concern plausible but unproven (PMID 42395176)Not shown, not ruled out
What is in the vialBlack market vials held altered versions of ipamorelin, GHRP-2 and GHRP-6 instead of the named peptides (PMID 29864719); mislabelled and contaminated supply flagged as a leading risk (PMID 41880199)Product identity
Regulatory statusCJC-1295 and ipamorelin placed in FDA Category 2 for compounding in September 2023, significant safety risks; tesamorelin approved for one condition onlyUnapproved for muscle
Anti dopingAll growth hormone releasing factors and secretagogues are banned by WADA under S2; GHRPs are detectable in urine (PMID 41880199, PMID 41476424)Tested athletes

The blood sugar signal deserves the most attention because it is the most consistent. Growth hormone opposes insulin by design. In the only year long trial of a secretagogue in healthy adults, fasting glucose rose and insulin sensitivity fell (PMID 18981485). In the two year capromorelin trial, glucose, glycosylated haemoglobin and insulin resistance all rose (PMID 19174493). A 2026 review of peptides in sport lists insulin resistance and dyslipidaemia among the emerging risks (PMID 41880199). Anyone running these compounds who gets blood work should expect that number to move. What the numbers mean is on blood tests before steroids.

A small peptide vial labelled GH, a blood collection tube and a glucose meter with a blank screen on a dark laboratory bench
The number most likely to move on a growth hormone peptide is not muscle mass. It is fasting glucose, in every long trial of the class.
Cat. 2Where the FDA placed CJC-1295 and ipamorelin in September 2023: Category 2 of the bulk drug substances list for 503A compounding, the category for significant safety risks. That effectively stops US pharmacies from compounding them. Clinics selling them after that date are working around the rule, not within it.

The practical risk is the supply. A 2018 analysis of black market growth hormone products found altered versions of ipamorelin, GHRP-2 and GHRP-6 (PMID 29864719). They were sold in place of the real thing. The general page on peptide side effects covers the sterility and injection problems shared by every mixed vial.

YouWhat this means for you. If you compete in a tested sport, this whole class is a clear no. For everyone else, the honest picture is a known set of growth hormone effects, water and blood sugar first, from compounds that have never been shown to build muscle, bought from a supply chain two labs have caught substituting.

Fat loss, women, and the other questions people ask

Best peptides for muscle growth and fat loss. The fat loss story has one real data point and it belongs to tesamorelin. Deep belly fat fell 15.2 percent in HIV patients over 26 weeks (PMID 18057338). Growth hormone itself cut fat mass in recreational athletes over eight weeks (PMID 20439575). MK-677 did not reduce visceral or total fat, and limb fat actually rose (PMID 18981485). No other peptide on this page has a fat loss result in people. The peptides that do have fat loss trials are the GLP-1 drugs, which are a different class entirely.

Best peptides for female muscle growth. The only trial that split results by sex found the lean mass gain, the insulin sensitivity gain and the wellbeing gain in men only. Women got thicker skin and nothing else (PMID 9141536). In the recreational athlete trial, women on growth hormone shared the sprint effect but not the testosterone combination arm (PMID 20439575). Nobody has run a growth hormone peptide trial designed around women who lift.

Oral hgh peptides for muscle growth. Peptides are digested, so oral versions of these compounds do not survive the stomach in any useful amount. MK-677 is the exception because it is not a peptide. It is a small molecule drug designed to be swallowed, and it is the only oral option with human data (PMID 18981485).

Peptides for muscle growth before and after. The before and after photos online show water and a few weeks of a calorie deficit at best. The trials say growth hormone adds about 2 kg of lean mass, mostly water. There was no change in muscle size you could photograph (PMID 18347346, PMID 1550219).

Are peptides safer than steroids? Different risks, not fewer. Anabolic steroids build muscle and carry heart, liver and hormone risks. Growth hormone peptides do not build measurable muscle in trials and carry water, joint and blood sugar risks (PMID 18347346, PMID 18981485). Safer than a drug that works is a strange way to describe a drug that has not been shown to work. How steroids act is on what are anabolic steroids.

YouWhat this means for you. The honest answers to the long tail questions are short. Fat loss: tesamorelin, for one condition. Women: no data. Oral: MK-677 only. Before and after: water. Safer than steroids: a different risk list on a compound without a muscle result.

Peptides for muscle growth in the gym: what users report, and what is measured

The trials cannot write this section, so it reports two things separately. First, how users describe running peptides for muscle growth. Second, the measured data that any of it could rest on. Nothing in the first part is evidence.

What users describe. The default stack in forum logs is CJC-1295 no DAC with ipamorelin, usually a blend vial. Users describe 100 micrograms of each per shot, one to three times a day, before bed and on waking on an empty stomach (vendor guides, forum posts). MK-677 is described at 10 to 25 mg a night, often for months, with hunger and water as the accepted price. Sermorelin and tesamorelin appear as clinic prescriptions at 200 to 300 micrograms and 1 to 2 mg a night. Most users run these alongside testosterone rather than instead of it, and most describe runs of eight to twelve weeks (forum posts). The reasons given are sleep, recovery, slow fat loss and a fuller look. The complaints are hunger, water, numb hands, tiredness, and a common verdict that the results were mild for the money (forum posts).

What the reasons rest on. Sleep: the biggest natural pulse comes in deep sleep, so a bedtime shot seems to fit, but no trial has measured sleep on a secretagogue. Recovery: no trial. Fat loss: tesamorelin in HIV patients and growth hormone in athletes, both real, both modest (PMID 18057338, PMID 20439575). The fuller look: water, which is exactly what the trials measured (PMID 1550219).

What is measured that a lifter could use. Two things. First, these compounds reliably raise growth hormone and, with repeated dosing, IGF-1, so blood work will show it. Second, blood sugar and insulin sensitivity move the wrong way with months of use (PMID 18981485, PMID 19174493). Anyone running a stack should know that the number most likely to change is not muscle mass but fasting glucose.

YouWhat this means for you. Users are not imagining the effects. Water, hunger, deeper sleep and a fuller look are real growth hormone effects. What the trials add is that none of it turned into measurable muscle or strength, and that the price shows up in blood sugar. How to tell a research chemical listing from a trial is on peptide research vs human use.

Five mistakes people make about growth hormone peptides

1. Assuming more growth hormone means more muscle

Growth hormone itself added lean mass but no strength or muscle size in fit adults who train (PMID 18347346, PMID 1550219). A peptide that raises your own hormone cannot beat that.

2. Ranking by popularity

The three most popular gym peptides, CJC-1295, ipamorelin and GHRP-6, have no body composition data in people. The least popular, MK-677, is the only one that does (PMID 18981485).

3. Borrowing tesamorelin results for the stack

The belly fat result belongs to an approved drug, in HIV patients, at 2 mg a day for 26 weeks under supervision (PMID 18057338). It does not transfer to a blend vial of two other peptides.

4. Ignoring blood sugar

In every long trial of a secretagogue, fasting glucose or insulin resistance went up (PMID 18981485, PMID 19174493). It is the most consistent finding in the class and the one users mention least.

5. Trusting the label on the vial

A doping lab found altered versions of ipamorelin, GHRP-2 and GHRP-6 sold as the named peptides (PMID 29864719). The FDA cited impurities when it barred compounding of CJC-1295 and ipamorelin.

Verdict: real hormone, small lean mass, no strength, and a blood sugar bill

Judged by the trials rather than the ads, growth hormone peptides do exactly one thing reliably. They raise your own growth hormone and, with repeated dosing, IGF-1 (PMID 2108187, PMID 16352683). Growth hormone itself, at doses above what the peptides produce, added about 2 kg of lean mass in fit young adults. It did not add strength or muscle size (PMID 18347346, PMID 1550219). The one secretagogue with a muscle number added 1.1 kg of lean mass in a year in older adults. It brought no strength gain and worse blood sugar (PMID 18981485). That is the field.

1.1 kgLean mass gained in a year on the only growth hormone secretagogue with a controlled human result, in people aged 60 to 81, with no change in strength and a rise in fasting glucose (PMID 18981485). Every other peptide on the list has hormone curves or nothing.

For readers here, the practical conclusion is simple. If you are chasing muscle, peptides for muscle growth have not shown they can deliver, even at the level of growth hormone itself. If you are chasing belly fat, the one drug with data is a prescription for one condition. The deep pages go further: CJC-1295, ipamorelin, and the healing side of the field on healing peptides. The syringe arithmetic for any vial is on the peptide calculator.

Growth hormone peptides: frequently asked questions

What are the best peptides for muscle growth?

Ranked by human evidence rather than popularity, three names lead. MK-677 added 1.1 kg of lean mass over a year in healthy older adults with no strength gain (PMID 18981485). Sermorelin added lean mass in older men but not women over 16 weeks (PMID 9141536). Tesamorelin cut belly fat in HIV patients but was not tested for muscle (PMID 18057338). CJC-1295, ipamorelin, GHRP-6 and hexarelin have no body composition data in people. None is approved for muscle growth.

Do peptides really work for muscle building?

They work for raising growth hormone. For muscle, the evidence is thin and points the wrong way. Growth hormone itself added about 2.1 kg of lean mass in fit young adults with no gain in strength or exercise capacity (PMID 18347346). In 16 young men lifting for 12 weeks, growth hormone did not add muscle size, strength or muscle protein synthesis beyond placebo (PMID 1550219). The only secretagogue with a lean mass result added 1.1 kg in a year with no strength gain (PMID 18981485).

What are hgh peptides?

Compounds that make your pituitary release more of your own growth hormone. GHRH analogs such as sermorelin, tesamorelin and CJC-1295 copy the hypothalamic signal. Growth hormone releasing peptides such as GHRP-6, GHRP-2, hexarelin and ipamorelin act on the ghrelin receptor. MK-677 is an oral drug on the same receptor. Using both doors at once releases more growth hormone than either alone (PMID 7883854). None of them is growth hormone itself.

Are peptides safer than steroids?

They carry a different list of risks, not a shorter one. Growth hormone peptides have not been shown to build measurable muscle in trials. They bring water retention, joint pain, raised cortisol and prolactin on most GHRPs, and worse blood sugar with months of use (PMID 18347346, PMID 18981485, PMID 2108187). The supply is unregulated and has been found mislabelled (PMID 29864719). They are banned in tested sport.

What is the best peptide for muscle growth and fat loss?

For fat, the only peptide with a human result is tesamorelin. It is an approved drug that cut deep belly fat 15.2 percent in HIV patients over 26 weeks (PMID 18057338). Growth hormone itself cut fat mass in recreational athletes (PMID 20439575). MK-677 did not reduce fat and increased limb fat (PMID 18981485). No peptide on this page has shown both muscle gain and fat loss in a human trial.

Which peptides are best for female muscle growth?

No trial has been designed around women who lift. The one trial that split results by sex found lean mass, insulin sensitivity and wellbeing gains in men only. Women got thicker skin and nothing else (PMID 9141536). The honest answer is that there is no female specific evidence for any growth hormone peptide.

What are the side effects of peptides for muscle growth?

Water retention, swelling, joint and muscle pain, fatigue and tingling, which are growth hormone effects (PMID 18347346, PMID 18981485). Raised cortisol and prolactin on GHRP-6 and hexarelin (PMID 2108187, PMID 8954038). Hunger on anything that hits the ghrelin receptor. The most consistent long term signal is higher fasting glucose and lower insulin sensitivity (PMID 18981485, PMID 19174493). And the vial may not contain what it says (PMID 29864719).

Is CJC-1295 ipamorelin good for muscle growth?

It has never been measured for muscle in a person. The combination has one study, in mice with steroid induced muscle loss (PMID 41476424). CJC-1295 has two phase 1 trials measuring hormones only (PMID 16352683), and the no DAC form in the blend vials was not in them. Ipamorelin failed its only efficacy trial (PMID 25331030). Both were placed in FDA Category 2 for compounding in 2023.

Sources and further reading

Every figure on this page comes from one of the 24 sources below. 23 are papers checked against their PubMed abstracts on 25 October 2026, and one is the FDA compounding list. How users describe these compounds is labelled as vendor guides and forum posts in the text and carries no reference number. Animal studies are cited as animal studies, never as human results. Reference links are dofollow to support open science.

1
Systematic review: the effects of growth hormone on athletic performance

Verified

Liu H, et al. Ann Intern Med. 2008;148(10):747-58. PMID 18347346

View on PubMed →

2
The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial

Verified

Meinhardt U, et al. Ann Intern Med. 2010;152(9):568-77. PMID 20439575

View on PubMed →

3
Effect of growth hormone and resistance exercise on muscle growth in young men

Verified

Yarasheski KE, et al. Am J Physiol. 1992;262(3 Pt 1):E261-7. PMID 1550219

View on PubMed →

4
Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial

Verified

Nass R, et al. Ann Intern Med. 2008;149(9):601-11. PMID 18981485

View on PubMed →

5
Effects of an oral growth hormone secretagogue in older adults

Verified

White HK, et al. J Clin Endocrinol Metab. 2009;94(4):1198-206. PMID 19174493

View on PubMed →

6
Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

Verified

Khorram O, et al. J Clin Endocrinol Metab. 1997;82(5):1472-9. PMID 9141536

View on PubMed →

7
Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

Verified

Bowers CY, et al. J Clin Endocrinol Metab. 1990;70(4):975-82. PMID 2108187

View on PubMed →

8
Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection

Verified

Popovic V, et al. J Clin Endocrinol Metab. 1995;80(3):942-7. PMID 7883854

View on PubMed →

9
GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults

Verified

Popovic V, et al. Lancet. 2000;356(9236):1137-42. PMID 11030292

View on PubMed →

10
A five day treatment with daily subcutaneous injections of growth hormone-releasing peptide-2 causes response attenuation and does not stimulate insulin-like growth factor-I secretion in healthy young men

Verified

Nijland EA, et al. Eur J Endocrinol. 1998;139(4):395-401. PMID 9820615

View on PubMed →

11
Ipamorelin, the first selective growth hormone secretagogue

Verified

Raun K, et al. Eur J Endocrinol. 1998;139(5):552-61. PMID 9849822

View on PubMed →

12
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers

Verified

Gobburu JV, et al. Pharm Res. 1999;16(9):1412-6. PMID 10496658

View on PubMed →

13
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients

Verified

Beck DE, et al. Int J Colorectal Dis. 2014;29(12):1527-34. PMID 25331030

View on PubMed →

14
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Verified

Teichman SL, et al. J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683

View on PubMed →

15
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog

Verified

Ionescu M, Frohman LA. J Clin Endocrinol Metab. 2006;91(12):4792-7. PMID 17018654

View on PubMed →

16
Metabolic effects of a growth hormone-releasing factor in patients with HIV

Verified

Falutz J, et al. N Engl J Med. 2007;357(23):2359-70. PMID 18057338

View on PubMed →

17
Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study

Verified

Massoud AF, et al. J Clin Endocrinol Metab. 1996;81(12):4338-41. PMID 8954038

View on PubMed →

18
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

Verified

Mayfield CK, et al. Am J Sports Med. 2026;54(1):223-229. PMID 41476424

View on PubMed →

19
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

Verified

Dominikowski A, et al. Front Endocrinol (Lausanne). 2026;17:1822475. PMID 42395176

View on PubMed →

20
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review

Verified

Coutinho LFD, et al. J Sports Med Phys Fitness. 2026;66(7):880-885. PMID 41880199

View on PubMed →

21
Analysis of new growth promoting black market products

Verified

Krug O, et al. Growth Horm IGF Res. 2018;41:1-6. PMID 29864719

View on PubMed →

22
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

Verified

Mendias CL, Awan TM. Sports Med. 2026;56(8):1921-1935. PMID 41966639

View on PubMed →

23
Peptide Supplements and Their Therapeutic Applications in Sports Medicine

Verified

Tewari K, et al. Am J Sports Med. 2026; online ahead of print. PMID 42578445

View on PubMed →

24
Certain bulk drug substances for use in compounding that may present significant safety risks (CJC-1295 and ipamorelin entries, Category 2, September 2023)

Regulator

US Food and Drug Administration, human drug compounding, accessed 25 October 2026.

View source →

Keep reading

Four pages that go deeper: the two most popular gym peptides line by line, the healing side of the field, and the syringe arithmetic for any vial.

DISCLAIMER

Final Educational Note

This article is educational and is not medical advice. It reports what the human trials of growth hormone and its secretagogues, the class reviews and the FDA and anti doping record say. It reports how some users describe these compounds as a description of a habit, not as guidance. Doses appear only as a trial states them. The page gives no schedule, cycle, stack or protocol, and does not recommend any growth hormone peptide for any use. It is not an encouragement to use research chemicals or performance enhancing drugs, which carry serious health and legal risks. More guides sit on the peptides hub.

Some signs need a doctor at once. Lasting headache, changes in vision, swelling of the hands or feet, numbness or tingling, rising fasting blood sugar, or a reaction that spreads from an injection site. Read more about how this site works on the about page and in the full disclaimer.

R
Ryan Hale
Research Notes Editor. Breaks down studies, mechanisms, supplements and peptides into clear performance focused education, and checks every citation against PubMed before publication.